Effect of NVPAEW541 and RAD001 on Cell Growth and Apoptosis in two Pancreatic Adenocarcinoma Cell lines.

被引：0
|
作者：
Warshamana-Greene, G. S. [1 ]
Panthi, A. [1 ]
机构：
[1] South Carolina State Univ, Biol Phys Sci, Orangeburg, SC USA
来源：
MOLECULAR BIOLOGY OF THE CELL | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
P2200
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The anticancer effects of RAD001 on glioma cell lines
    LaFortune, T
    Liu, TJ
    Yung, WKA
    NEURO-ONCOLOGY, 2004, 6 (04) : 332 - 332
  • [2] Radiosensitization by the mTOR inhibitor RAD001 involves the induction of autophagy in two cancer cell lines
    Bischoff, Pierre L.
    Altmeyer, Anais
    Josset, Elodie
    Denis, Jean -Marc
    Gueulette, John
    Slabbert, Jakobus P.
    Noel, Georges
    CANCER RESEARCH, 2012, 72
  • [3] RAD001, An Inhibitor of mTOR, Enhances Monocytic Differentiation Induced by ATRA through Phosphorylation of C/EBPα In AML Cell Lines.
    Yoshida, Hideki
    Imamura, Toshihiko
    Fujiki, Atsushi
    Hirashima, Yoshifumi
    Miyachi, Mitsuru
    Sugita, Kanji
    Hosoi, Hajime
    BLOOD, 2010, 116 (21) : 889 - 889
  • [4] Effect of triptolide on gemcitabine-mediated apoptosis in pancreatic cancer cell lines.
    Wang, Wei
    Lin, Wenjie
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] Synergistic inhibition of osteosarcoma cell growth by combinaison of RAD001 (everolimus) and Zoledronic acid
    Heymann, D.
    Moriceau, G.
    Ory, B.
    Mitrofan, L.
    Charrier, C.
    Brion, R.
    Pilet, P.
    Shultz, L.
    Monkkonen, J.
    Redini, F.
    BONE, 2010, 47 : S314 - S314
  • [6] Synergistic inhibition of osteosarcoma cell growth by combination of RAD001 (everolimus) and zoledronic acid
    Moriceau, G.
    Ory, B.
    Mitrofan, L.
    Brion, R.
    Charrier, C.
    Pilet, P.
    Shultz, L.
    Monkkonen, J.
    Redini, F.
    Heymann, D.
    BONE, 2009, 44 (02) : S240 - S241
  • [7] The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell lines
    Brigette B. Y. Ma
    Vivian W. Y. Lui
    Edwin P. Hui
    Cecilia P. Y. Lau
    Kakiu Ho
    Margaret H. L. Ng
    S. H. Cheng
    Sai-Wah Tsao
    Anthony T. C. Chan
    Investigational New Drugs, 2010, 28 : 413 - 420
  • [8] Activity of mTOR-Inhibitor Rad001 (everolimus) in differentiated and anaplastic thyroid cancer cell lines
    Behlendorf, T.
    Voigt, W.
    Mueller, T.
    Jordan, K.
    Arnold, D.
    Schmoll, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell lines
    Ma, Brigette B. Y.
    Lui, Vivian W. Y.
    Hui, Edwin P.
    Lau, Cecilia P. Y.
    Ho, Kakiu
    Ng, Margaret H. L.
    Cheng, S. H.
    Tsao, Sai-Wah
    Chan, Anthony T. C.
    INVESTIGATIONAL NEW DRUGS, 2010, 28 (04) : 413 - 420
  • [10] Characterisation and defining interactions of cadherin and catenin complexes in pancreatic adenocarcinoma cell lines.
    El-Hariry, I
    Lemoine, NR
    Pignatelli, M
    JOURNAL OF PATHOLOGY, 1998, 184 : 37A - 37A
12345